|
Synonyms: ALN-18328 | ALN-TTR02 | Onpattro®
patisiran is an approved drug (EMA & EMA & FDA (2018), UK MHRA (2021))
Compound class:
Nucleic acid
Comment: Patisiran (ALN-TTR02) is a double-stranded small interfering RNA (siRNA) class drug [2]. It reduces hepatic production of mutated transthyretin protein, as a mechanism to treat hereditary transthyretin amyloidosis with polyneuropathy [1,3-4]. We have been unable to locate a full chemical SMILES for the drug, or its HELM notation.
|
